Monique Kosse | IR |
Sharon Malka | CEO |
Boaz Gur-Lavie | Chief Financial Officer |
Ofer Gonen | Board Member |
Lior Rosenberg | Chief Medical Officer |
Cyaandi R. Dove | Investigator, Advanced Wound & Ankle Center, Las Vegas |
Unidentified Analyst | Cowen and Company |
Kevin DeGeeter | Oppenheimer |
Arthur He | H.C. Wainwright |
Good day and welcome to the MediWound First Quarter 2022 Financial Results and Presentation of the EscharEx Phase 2 Clinical Trial Results Conference Call. At this time all participants are in a listen-only mode.
Following management’s prepared remarks we will hold a Q&A session. [Operator Instructions]. At this time I would like to turn the conference over to Monique Kosse of LifeSci Advisors.